STOCKHOLDERS' DEFICIT (Details 6) |
3 Months Ended |
|---|---|
|
Mar. 31, 2022
$ / shares
shares
| |
| Class Of Warrant Or Right [Line Items] | |
| Number of Warrants Issued, Outstanding | 8,236,017 |
| Total, Exercisable | 6,986,017 |
| Warrants Issued Prior to January 1, 2020 - Exercise Price $1.54-$36.24 [Member] | |
| Class Of Warrant Or Right [Line Items] | |
| Number of Warrants Issued, Outstanding | 8,236,017 |
| Weighted Average Remaining Contractual Life (Years), Outstanding | 1 year 11 months 23 days |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 5.87 |
| Total, Exercisable | 6,986,017 |
| Weighted Average Exercise Price, Exercisable | $ / shares | $ 5.87 |
| X | ||||||||||
- Definition The number of warrants exercisable as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price per share or per unit of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average price for exercisable warrants when converting warrants into shares. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|